MET exon 14 mutations as targets in routine molecular analysis of primary sarcomatoid carcinoma of the lung

This publication has 16 references indexed in Scilit:

• Characterization of 298 Patients with Lung Cancer Harboring MET Exon 14 Skipping Alterations
  Journal of Thoracic Oncology, 2016
• Next-Generation Sequencing of Pulmonary Sarcomatoid Carcinoma Reveals High Frequency of Actionable MET Gene Mutations
  Journal of Clinical Oncology, 2016
• MET Exon 14 Mutations in Non–Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent MET Genomic Amplification and c-Met Overexpression
  Journal of Clinical Oncology, 2016
• Activation of MET via Diverse Exon 14 Splicing Alterations Occurs in Multiple Tumor Types and Confers Clinical Sensitivity to MET Inhibitors
  Cancer Discovery, 2015
• Transcriptome meta-analysis of lung cancer reveals recurrent aberrations in NRG1 and Hippo pathway genes
  Nature Communications, 2014
• Blood vessel invasion is a major feature and a factor of poor prognosis in sarcomatoid carcinoma of the lung
  Lung Cancer, 2014
• Outcomes of sarcomatoid carcinoma of the lung: A Surveillance, Epidemiology, and End Results database analysis
  Surgery, 2012
• Increased MET Gene Copy Number Negatively Affects Survival of Surgically Resected Non–Small-Cell Lung Cancer Patients
  Journal of Clinical Oncology, 2009
• The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours
  Journal of Thoracic Oncology, 2007
• Functional Expression and Mutations of c-Met and Its Therapeutic Inhibition with SU11274 and Small Interfering RNA in Non–Small Cell Lung Cancer
  Cancer Research, 2005